IL-6 knockout mice are protected from cocaine-induced kindling behaviors; possible involvement of JAK2/STAT3 and PACAP signalings

Food Chem Toxicol. 2018 Jun;116(Pt B):249-263. doi: 10.1016/j.fct.2018.04.031. Epub 2018 Apr 16.

Abstract

IL-6 has been recognized as an anticonvulsant against certain neuroexcitotoxicities. We aimed to investigate on the interactive role between IL-6 and PACAP in cocaine-induced kindling behaviors. Although we found that cocaine (45 mg/kg, i.p./day x 5) significantly increased IL-6 and TNF-α expression, it resulted in a decrease in IFN-γ expression. We observed that the cocaine-induced increase in IL-6 expression was more pronounced than that in TNF-α expression. Genetic depletion of IL-6 significantly activated cocaine kindling behaviors. This phenomenon was also consistently observed in WT mice that received a neutralizing IL-6 receptor antibody. Cocaine-treated IL-6 knockout mice exhibited significantly decreased PACAP and PACAP receptor (PAC1R) mRNA levels and significantly increased TNF-α gene expression. TNF-α knockout mice were protected from cocaine kindling via an up-regulation of IL-6, phospho-JAK2/STAT3, PACAP, and PAC1R levels, which produced anti-apoptotic effects. Recombinant IL-6 protein (rIL-6, 2 μg, i.v./mouse/day x 5) also up-regulated phospho-JAK2/STAT3, PACAP, and PAC1R mRNA levels, leading to anti-apoptotic effects in IL-6 knockout mice. Consistently, AG490, a JAK2/STAT3 inhibitor, and PACAP 6-38, a PAC1 receptor antagonist, counteracted rIL-6-mediated protection. Combined, our results suggest that IL-6 gene requires up-regulation of phospho-JAK2/STAT3, PACAP, and PAC1R and down-regulation of the TNF-α gene to modulate its anticonvulsive/neuroprotective potential.

Keywords: Cocaine-induced kindling (convulsive) behaviors; Hippocampus; Interleukin-6 knockout mice; JAK2/STAT3; Pituitary adenylate cyclase-activating polypeptide; Tumor necrosis factor-α knockout mice.

MeSH terms

  • Animals
  • Antibodies, Neutralizing / immunology
  • Cocaine / toxicity*
  • Down-Regulation
  • Hippocampus / drug effects*
  • Hippocampus / metabolism
  • Interferon-gamma / genetics
  • Interferon-gamma / metabolism
  • Interleukin-6 / genetics
  • Interleukin-6 / immunology
  • Interleukin-6 / metabolism
  • Interleukin-6 / physiology*
  • Janus Kinase 2 / metabolism*
  • Kindling, Neurologic / drug effects*
  • Male
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Neuroprotective Agents / pharmacology
  • Phosphorylation
  • Pituitary Adenylate Cyclase-Activating Polypeptide / metabolism*
  • Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I / agonists
  • Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I / genetics
  • STAT3 Transcription Factor / metabolism*
  • Signal Transduction / drug effects*
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / metabolism
  • Tyrphostins / pharmacology
  • Up-Regulation

Substances

  • Antibodies, Neutralizing
  • Interleukin-6
  • Neuroprotective Agents
  • Pituitary Adenylate Cyclase-Activating Polypeptide
  • Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I
  • STAT3 Transcription Factor
  • Stat3 protein, mouse
  • Tumor Necrosis Factor-alpha
  • Tyrphostins
  • alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide
  • Interferon-gamma
  • Jak2 protein, mouse
  • Janus Kinase 2
  • Cocaine